References
Ayala F, Antolin S, Gavilá J, González L, Henao F, Martínez MT, et al. SEOM-GEICAM-SOLTI clinical guidelines for early-stage breast cancer (2022). Clin Transl Oncol. 2023. https://doi.org/10.1007/s12094-023-03215-4 (Online ahead of print).
Gradishar WJ, Moran MS, Abraham J, Abramson V, Aft R, Agnese D, et al. NCCN Guidelines® insights: breast cancer, version 4.2023. Natl Compr Canc Netw. 2023;21(6):594–608. https://doi.org/10.6004/jnccn.2023.0031.
Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, et al. Estimating the benefits of therapy for early-stage breast cancer. The St. Gallen International Consensus guidelines for the primary therapy of early breast cancer 2019. Ann Oncol. 2019;30:1541–57.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
There is no conflict of interest of any of the authors.
Ethical approval (Research involving human participants and/or animals)
There is no research involving humans or animals.
Informed consent
No need of informed consent as it is a letter answering an article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Pardo García, R., Piñero Madrona, A., Algara López, M. et al. Just medical oncology guidelines…. Clin Transl Oncol 25, 3319–3320 (2023). https://doi.org/10.1007/s12094-023-03272-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-023-03272-9